Speaker illustration

Doctor Ryutaro Shimada

Yahaba (Japan)

Impact of procedural and patient-related risks on 1-year outcomes for patients with 1-month DAPT followed by P2Y12 inhibitor monotherapy after biodegradable-polymer drug-eluting stent implantation

Event: ESC Congress 2024

Topic: Pharmacotherapy

Session: Data-driven decisions for anticoagulant and antiplatelet therapy

Thumbnail